The CACNA1F Gene Cone-rod dystrophy X-linked type 3 Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the CACNA1F gene, which are associated with Cone-rod dystrophy X-linked type 3, a rare genetic disorder. This condition primarily affects the eyes, leading to a progressive loss of vision due to the deterioration of cone and rod cells in the retina. The test is crucial for early diagnosis, allowing for appropriate management and counseling for affected individuals and their families.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the CACNA1F gene. The results can provide invaluable information for affected individuals, including insights into the progression of the disease, potential treatments, and the risk of passing the condition on to offspring.
The cost of the CACNA1F Gene Cone-rod dystrophy X-linked type 3 Genetic Test is set at 4400 AED, reflecting the sophisticated technology and expert analysis required to accurately identify mutations in the CACNA1F gene. While the price may seem high, the information gained from this test can be critical for the effective management of Cone-rod dystrophy X-linked type 3, significantly impacting the quality of life for those diagnosed with this challenging condition.
The TGFBI Gene Corneal Dystrophy Epithelial Basement Membrane Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TGFBI gene that are associated with various types of corneal dystrophies, including epithelial basement membrane dystrophy (EBMD). EBMD, also known as map-dot-fingerprint dystrophy, is a common eye condition that can lead to vision impairment due to irregularities in the cornea's epithelial basement membrane. The test plays a crucial role in the accurate diagnosis and management of patients affected by or at risk of developing this condition.
By analyzing the patient's DNA, the test can pinpoint specific genetic mutations in the TGFBI gene, offering valuable insights into the disease's prognosis, potential treatment strategies, and the risk of inheritance for family members. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to conduct this sophisticated genetic analysis. Conducted at DNA Labs UAE, a leading facility in genetic testing, this service ensures high accuracy and reliability, providing essential information for patients and healthcare providers in managing corneal dystrophies effectively.
The VSX1 gene test for Corneal Dystrophy, Posterior Polymorphous Type 1 (PPCD1), is a specialized genetic analysis offered by DNA Labs UAE. This test is designed to identify mutations in the VSX1 gene, which have been associated with PPCD1, a rare genetic disorder affecting the cornea. PPCD1 is characterized by changes in the endothelial cells lining the back of the cornea, leading to corneal edema, blisters on the cornea, and vision problems. The VSX1 gene test is crucial for diagnosing the condition, understanding its genetic basis, and guiding treatment decisions.
The cost of the VSX1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any genetic abnormalities in the VSX1 gene that may lead to PPCD1. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of the condition, enabling informed decisions about management and potential interventions to preserve vision and improve quality of life.
The SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the SLC4A11 gene, which are associated with the development of Corneal Endothelial Dystrophy Type 2 (CHED2). This condition is a rare, inherited eye disorder that primarily affects the endothelium, the innermost layer of the cornea, leading to swelling, blurred vision, and potentially severe visual impairment.
The test is crucial for individuals with a family history of CHED2 or those exhibiting symptoms, as early detection can facilitate timely management and treatment options to preserve vision. Conducted through a blood sample or buccal swab, the test specifically looks for genetic abnormalities in the SLC4A11 gene, which plays a significant role in maintaining corneal transparency and hydration.
Priced at 4400 AED, the genetic test at DNA Labs UAE is performed with high precision and accuracy, providing individuals and their healthcare providers with vital information for making informed decisions regarding the condition's management and treatment. The test not only aids in the diagnosis but also helps in understanding the risk of passing the condition to future generations, thereby playing a significant role in family planning and genetic counseling.
The "NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the NLRP1 gene, which are linked to corneal intraepithelial dyskeratosis and ectodermal dysplasia. These conditions are part of a group of disorders that affect the skin, hair, nails, and occasionally the teeth and sweat glands, often leading to symptoms from birth or early childhood. Corneal intraepithelial dyskeratosis specifically impacts the eyes, leading to vision problems due to abnormal growth of the cornea.
The test, priced at 4400 AED, utilizes advanced genetic sequencing techniques to analyze the NLRP1 gene, aiming to provide accurate diagnosis and insights. This information is crucial for understanding the risk of passing the condition to offspring, planning treatments, and managing symptoms effectively. Conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic diagnostics, this test represents a significant step forward in personalized medicine and genetic understanding of complex dermatological and ocular conditions.
The PXDN gene plays a crucial role in ocular development and function. Mutations in this gene have been linked to corneal opacification and various other ocular anomalies, which can impact vision quality and lead to significant visual impairment. To identify mutations in the PXDN gene that may contribute to these conditions, DNA Labs UAE offers a specialized genetic test.
This genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the PXDN gene that could be responsible for the development of corneal opacification and other related ocular anomalies. Early detection through this test can be crucial for the management and treatment of these conditions, offering a chance to mitigate the progression of symptoms and improve the patient's quality of life.
The test is priced at 4400 AED and is conducted in DNA Labs UAE's state-of-the-art facilities. The lab employs cutting-edge technology and adheres to the highest standards of accuracy and reliability in genetic testing. Upon completion, a comprehensive report is provided, detailing the findings and, if applicable, recommendations for follow-up care or interventions. This test is an invaluable tool for individuals at risk of PXDN gene-related ocular conditions, enabling proactive healthcare decisions.
The EFEMP1 gene test for Doyne honeycomb retinal dystrophy, offered by DNA Labs UAE, is a genetic screening aimed at detecting mutations in the EFEMP1 gene, which is associated with this specific form of retinal dystrophy. Doyne honeycomb retinal dystrophy, also known as Malattia Leventinese, is an inherited eye disorder characterized by the accumulation of drusen (yellow deposits) beneath the retina, leading to progressive vision loss. The test is crucial for individuals with a family history of the condition or those experiencing symptoms, providing valuable insights into their genetic predisposition.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the EFEMP1 gene test involves collecting a DNA sample, typically through a blood draw or cheek swab. The laboratory then analyzes the sample to identify any mutations in the EFEMP1 gene that could indicate the presence of or risk for developing Doyne honeycomb retinal dystrophy.
The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology employed in detecting the genetic markers associated with the condition. For patients and families, the results from this test can guide clinical decisions, including early intervention and management strategies, to preserve vision and improve quality of life. It also offers the chance for affected families to understand their risk of passing the condition onto future generations, aiding in informed family planning decisions.
The CHN1 Gene Duane Retraction Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CHN1 gene, which are associated with Duane Retraction Syndrome (DRS). DRS is a rare congenital eye movement disorder characterized by limited horizontal eye movement, retraction of the eyeball into the socket, and, in some cases, other abnormalities. This condition results from abnormal development of the eye muscles, with the CHN1 gene playing a critical role in this process.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies in the CHN1 gene that might be responsible for the syndrome. This genetic testing is crucial for accurate diagnosis, helping in the management and treatment planning for individuals affected by DRS. It also offers valuable information for family planning to those who have a history of the syndrome in their family.
At DNA Labs UAE, the CHN1 Gene Duane Retraction Syndrome Genetic Test is priced at 4400 AED. This cost encompasses the entire process, from sample collection to genetic analysis and the provision of results. By offering this test, DNA Labs UAE provides an essential service for the early and accurate diagnosis of Duane Retraction Syndrome, facilitating better outcomes for those affected by this genetic condition.
The SALL4 Gene Duane Retraction Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SALL4 gene, which are linked to Duane Retraction Syndrome (DRS). This condition is a rare, congenital eye disorder characterized by limited horizontal eye movement, which often results in the retraction of the eyeball into the socket or other eye abnormalities. Early and accurate diagnosis through this genetic test allows for better management and understanding of the condition, potentially leading to more effective treatment plans and supportive care.
The test involves a detailed analysis of the SALL4 gene to pinpoint specific genetic alterations responsible for the syndrome. It is a critical step for families seeking answers about the genetic underpinnings of DRS and its potential impact on their health and development.
The cost of the SALL4 Gene Duane Retraction Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to accurately assess the presence of mutations in the SALL4 gene, providing essential insights for affected individuals and their families. The test is conducted in a state-of-the-art laboratory setting, ensuring high-quality standards and reliable results.
The ADAR Gene Dyschromatosis Symmetrica Hereditaria Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ADAR gene, which are known to cause Dyschromatosis Symmetrica Hereditaria (DSH). DSH is a rare genetic disorder characterized by a mixture of hyperpigmented and hypopigmented macules, primarily affecting the back of the hands and feet, and sometimes the face. These skin changes usually appear in early childhood and can vary significantly in pattern and extent among affected individuals.
This genetic test is crucial for confirming a diagnosis of DSH, allowing for appropriate management and counseling. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect mutations in the ADAR gene that are indicative of the condition. The process is thorough and is carried out by highly skilled professionals who ensure the accuracy and confidentiality of the results.
The cost of the ADAR Gene Dyschromatosis Symmetrica Hereditaria Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem steep, it reflects the sophisticated technology and expertise required to perform such a specialized test. For families and individuals facing the possibility of DSH, this test provides invaluable information that can guide decisions about treatment and management, as well as offer insights into the risk of passing the condition on to future generations.
